Incyte Biosciences Japan Gk

This study is for Japanese adults with Non-Hodgkin lymphoma, a type of blood cancer. Researchers are testing a drug called tafasitamab, alone or combined with other medicines, to see if it is safe and helps shrink tumors. About 72 people will take part. The goal is to find the be…

This study tests a drug called axatilimab in Japanese patients with chronic graft-versus-host disease (cGVHD) that has not responded to at least two prior treatments. cGVHD is a complication after a stem cell or bone marrow transplant where the donor cells attack the patient's bo…